Podcast Episode Details
Back to Podcast Episodes
Interview with CEO Martin Gouldstone of Oncimmune
Episode 1943
In this upbeat interview, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services that are used to enable precision medicine within the Biopharma industry – takes me through today’s positive yearend trading update, 3 contract wins and exciting road ahead.
Published on 1 year, 3 months ago